Atai Life Sciences ROA 2020-2023 | ATAI
Current and historical return on assets (ROA) values for Atai Life Sciences (ATAI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Atai Life Sciences ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-09-30 | $-0.07B | $0.31B | -23.34% |
| 2023-06-30 | $-0.15B | $0.25B | -49.03% |
| 2023-03-31 | $-0.15B | $0.28B | -46.64% |
| 2022-12-31 | $-0.15B | $0.31B | -44.32% |
| 2022-09-30 | $-0.20B | $0.34B | -52.89% |
| 2022-06-30 | $-0.19B | $0.35B | -47.58% |
| 2022-03-31 | $-0.21B | $0.38B | -45.86% |
| 2021-12-31 | $-0.17B | $0.41B | -43.12% |
| 2021-09-30 | $-0.17B | $0.48B | -52.93% |
| 2021-06-30 | $-0.22B | $0.51B | -113.76% |
| 2021-03-31 | $-0.19B | $0.15B | -287.94% |
| 2020-12-31 | $-0.17B | $0.11B | -607.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.329B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $15.996B | 9.68 |
| Quest Diagnostics (DGX) | United States | $14.102B | 14.58 |
| DaVita (DVA) | United States | $11.194B | 15.23 |
| Chemed (CHE) | United States | $9.133B | 28.74 |
| Encompass Health (EHC) | United States | $7.980B | 21.89 |
| Elanco Animal Health (ELAN) | United States | $6.611B | 15.07 |
| Option Care Health (OPCH) | United States | $5.261B | 20.59 |
| RadNet (RDNT) | United States | $3.273B | 95.60 |
| Amedisys (AMED) | United States | $2.971B | 21.20 |
| LifeStance Health (LFST) | United States | $2.166B | 0.00 |
| Astrana Health (ASTH) | United States | $2.073B | 26.16 |
| Addus HomeCare (ADUS) | United States | $1.568B | 24.03 |
| U.S Physical Therapy (USPH) | United States | $1.478B | 38.33 |
| Pennant (PNTG) | United States | $0.608B | 35.10 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.427B | 0.00 |
| Daxor (DXR) | United States | $0.046B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.010B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |